home / stock / cvac / cvac short
Short Information | CureVac N.V. (NASDAQ:CVAC)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 4,072,634 |
Total Actual Volume | 23,004,753 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 203,632 |
Average Short Percentage | 18.08% |
Is there a CVAC Short Squeeze or Breakout about to happen?
See the CVAC Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $3.35 | $3.34 | $3.46 | $3.28 | 670,907 | 183,069 | 27.29% |
07-01-2024 | $3.4 | $3.33 | $3.5687 | $3.33 | 708,328 | 116,702 | 16.48% |
06-28-2024 | $3.36 | $3.4 | $3.42 | $3.28 | 441,469 | 74,462 | 16.87% |
06-27-2024 | $3.34 | $3.36 | $3.4 | $3.23 | 502,032 | 97,891 | 19.5% |
06-26-2024 | $3.53 | $3.365 | $3.65 | $3.16 | 1,144,940 | 287,111 | 25.08% |
06-25-2024 | $3.5 | $3.54 | $3.6875 | $3.4 | 828,865 | 166,950 | 20.14% |
06-24-2024 | $3.29 | $3.47 | $3.56 | $3.26 | 904,093 | 270,270 | 29.89% |
06-21-2024 | $3.28 | $3.26 | $3.35 | $3.195 | 546,609 | 92,389 | 16.9% |
06-20-2024 | $3.38 | $3.26 | $3.388 | $3.18 | 616,163 | 93,174 | 15.12% |
06-18-2024 | $3.47 | $3.25 | $3.5091 | $3.13 | 1,191,387 | 342,595 | 28.76% |
06-17-2024 | $3.6 | $3.48 | $3.63 | $3.43 | 763,288 | 98,888 | 12.96% |
06-14-2024 | $3.85 | $3.67 | $3.85 | $3.58 | 1,174,371 | 91,724 | 7.81% |
06-13-2024 | $4.1 | $4 | $4.15 | $3.925 | 806,615 | 75,837 | 9.4% |
06-12-2024 | $4.3 | $4.15 | $4.58 | $4.1201 | 730,337 | 124,742 | 17.08% |
06-11-2024 | $4.5 | $4.25 | $4.5 | $4.01 | 1,384,811 | 213,995 | 15.45% |
06-10-2024 | $4.46 | $4.59 | $4.595 | $4.27 | 992,798 | 163,624 | 16.48% |
06-07-2024 | $4.84 | $4.49 | $4.9 | $4.465 | 1,734,608 | 296,106 | 17.07% |
06-06-2024 | $4.98 | $4.99 | $5.28 | $4.63 | 3,875,277 | 619,023 | 15.97% |
06-05-2024 | $4.19 | $4.53 | $4.57 | $4.13 | 2,020,818 | 266,814 | 13.2% |
06-04-2024 | $4.43 | $4.04 | $4.56 | $4 | 1,967,037 | 397,268 | 20.2% |
News, Short Squeeze, Breakout and More Instantly...
Phase 2 study to assess updated formulations for improved immune responses of multivalent vaccine candidate against influenza B strain Study initiated following previously reported interim data from Phase 2 Part of combined Phase 1/2 study in seasonal influenza Composition of vaccine ca...
Organizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year end U.S. FDA Fast Track designation granted for pre-pandemic avian influenza (H5N1) vaccine currently in Phase 1 development; candidate jointly developed with GSK Settlement wi...
CureVac N.V. (NASDAQ: CVAC) is one of today's top gainers. The company's shares have moved 23.1% on the day to $4.05. CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing pr...